Terms: = Liver cancer AND LMNA, EMD2, 4000, ENSG00000160789, LGMD1B, LDP1, PRO1, LMNC, FPLD, CDDC, HGPS, P02545, LFP, IDC, CMD1A, CDCD1, LMN1, CMT2B1, FPL AND Treatment
75 results:
1. Prediction of transformation in the histopathological growth pattern of colorectal liver metastases after chemotherapy using CT-based radiomics.
Wei S; Gou X; Zhang Y; Cui J; Liu X; Hong N; Sheng W; Cheng J; Wang Y
Clin Exp Metastasis; 2024 Apr; 41(2):143-154. PubMed ID: 38416301
[TBL] [Abstract] [Full Text] [Related]
2. Case 322: Pyothorax-associated Lymphoma.
Hu JY; Lee KH; Yun G
Radiology; 2024 Feb; 310(2):e223090. PubMed ID: 38411510
[TBL] [Abstract] [Full Text] [Related]
3. TRIP6 a potential diagnostic marker for colorectal cancer with glycolysis and immune infiltration association.
Liu XS; Chen YX; Wan HB; Wang YL; Wang YY; Gao Y; Wu LB; Pei ZJ
Sci Rep; 2024 Feb; 14(1):4042. PubMed ID: 38369589
[TBL] [Abstract] [Full Text] [Related]
4. The association between KRAS and histopathological growth patterns and the impact on resection margins around vasculature and bile ducts in colorectal liver metastases.
Wong P; Wong GYM; Toon CW; Chapuis P; Hugh TJ
ANZ J Surg; 2024 Apr; 94(4):560-565. PubMed ID: 38366706
[TBL] [Abstract] [Full Text] [Related]
5. [A Case of Triple Negative Breast cancer with Successful Control of Recurrent Disease Activity for More than Ten Years].
Yabe N; Watanuki R; Harada Y; Kondo A; Yanagisawa T; Maeda H; Kishi M; Yoshikawa T; Osumi K; Kamiya N; Sotome K; Ishii Y; Jinno H; Ikeda T; Watanabe M
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1759-1761. PubMed ID: 38303198
[TBL] [Abstract] [Full Text] [Related]
6. TH-4000, a hypoxia-activated pan-HER inhibitor, shows excellent preclinical efficacy for the treatment of HER2
Shao X; Yang D; Shan L; Yan X; Xu D; Li L; Sun Y; Yu Q; Zhou H; Ding Y; Tang J
Arch Toxicol; 2024 Mar; 98(3):865-881. PubMed ID: 38212449
[TBL] [Abstract] [Full Text] [Related]
7. Case 322.
Hu JY; Lee KH; Yun G
Radiology; 2023 Oct; 309(1):e223089. PubMed ID: 37906006
[TBL] [Abstract] [Full Text] [Related]
8. A CT-based radiomics nomogram for predicting histopathologic growth patterns of colorectal liver metastases.
Sun C; Liu X; Sun J; Dong L; Wei F; Bao C; Zhong J; Li Y
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9543-9555. PubMed ID: 37221440
[TBL] [Abstract] [Full Text] [Related]
9. Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution.
Fleischer JR; Schmitt AM; Haas G; Xu X; Zeisberg EM; Bohnenberger H; Küffer S; Teuwen LA; Karras PJ; Beißbarth T; Bleckmann A; Planque M; Fendt SM; Vermeulen P; Ghadimi M; Kalucka J; De Oliveira T; Conradi LC
Mol Cancer; 2023 Jan; 22(1):17. PubMed ID: 36691028
[TBL] [Abstract] [Full Text] [Related]
10. Pulse Parameters and Thresholds for (ir)Reversible Electroporation on Hepatocellular Carcinoma Cells
Lindelauf KHK; Baragona M; Baumann M; Maessen RTH; Ritter A
Technol Cancer Res Treat; 2023; 22():15330338221136694. PubMed ID: 36600679
[TBL] [Abstract] [Full Text] [Related]
11. Circulating tumour cells are associated with histopathological growth patterns of colorectal cancer liver metastases.
Meyer YM; Wilting SM; Kraan J; Olthof P; Vermeulen P; Martens J; Grünhagen DJ; Sleijfer S; Verhoef C
Clin Exp Metastasis; 2023 Feb; 40(1):69-77. PubMed ID: 36326981
[TBL] [Abstract] [Full Text] [Related]
12. Clinical implications and mechanism of histopathological growth pattern in colorectal cancer liver metastases.
Kong BT; Fan QS; Wang XM; Zhang Q; Zhang GL
World J Gastroenterol; 2022 Jul; 28(26):3101-3115. PubMed ID: 36051338
[TBL] [Abstract] [Full Text] [Related]
13. The relationship between primary colorectal cancer histology and the histopathological growth patterns of corresponding liver metastases.
Höppener DJ; Stook JPL; Galjart B; Nierop PMH; Nagtegaal ID; Vermeulen PB; Grünhagen DJ; Verhoef C; Doukas M;
BMC Cancer; 2022 Aug; 22(1):911. PubMed ID: 35996090
[TBL] [Abstract] [Full Text] [Related]
14. "A new LC-MS/MS method for the simultaneous quantification of abemaciclib, its main active metabolites M2 and M20, and letrozole for therapeutic drug monitoring".
Soledad Poetto A; Posocco B; Zanchetta M; Gagno S; Orleni M; Canil G; Alberti M; Puglisi F; Toffoli G
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Sep; 1207():123403. PubMed ID: 35940043
[TBL] [Abstract] [Full Text] [Related]
15. CT, MRI, and radiomics studies of liver metastasis histopathological growth patterns: an up-to-date review.
Li S; Li Z; Huang X; Zhang P; Deng J; Liu X; Xue C; Zhang W; Zhou J
Abdom Radiol (NY); 2022 Oct; 47(10):3494-3506. PubMed ID: 35895118
[TBL] [Abstract] [Full Text] [Related]
16. Biomarker profile of invasive lobular carcinoma: pleomorphic versus classic subtypes, clinicopathological characteristics and prognosis analyses.
Zhang Y; Luo X; Chen M; Yang L; Lei T; Pu T; Wei B; Bu H; Zhang Z
Breast Cancer Res Treat; 2022 Jul; 194(2):279-295. PubMed ID: 35666367
[TBL] [Abstract] [Full Text] [Related]
17. The Therapeutic Effect of
Meng F; Lin Y; Hu L; Feng W; Su P; Wu L
J Healthc Eng; 2022; 2022():7282453. PubMed ID: 35463673
[No Abstract] [Full Text] [Related]
18. Phase I study of [
Thivat E; Rouanet J; Auzeloux P; Sas N; Jouberton E; Levesque S; Billoux T; Mansard S; Molnar I; Chanchou M; Fois G; Maigne L; Chezal JM; Miot-Noirault E; D'Incan M; Durando X; Cachin F
BMC Cancer; 2022 Apr; 22(1):417. PubMed ID: 35428211
[TBL] [Abstract] [Full Text] [Related]
19. A review on the added value of whole-body MRI in metastatic lobular breast cancer.
Bhaludin BN; Tunariu N; Koh DM; Messiou C; Okines AF; McGrath SE; Ring AE; Parton MM; Sharma B; Gagliardi T; Allen SD; Pope R; Johnston SRD; Downey K
Eur Radiol; 2022 Sep; 32(9):6514-6525. PubMed ID: 35384456
[TBL] [Abstract] [Full Text] [Related]
20. Local tumour control after radiofrequency or microwave ablation for colorectal liver metastases in relation to histopathological growth patterns.
Vles MD; Höppener DJ; Galjart B; Moelker A; Vermeulen PB; Grünhagen DJ; Verhoef C
HPB (Oxford); 2022 Sep; 24(9):1443-1452. PubMed ID: 35144863
[TBL] [Abstract] [Full Text] [Related]
[Next]
